EILEEN MCCOLE: Open Payments
NPI 1194490789 · HORSHAM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,396 in 207 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $574 · 2025 $4,396
Food & beverage: $4,317Education: $79
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 42 | $940 |
| AstraZeneca Pharmaceuticals LP | 31 | $642 |
| Verona Pharma, Inc. | 23 | $379 |
| GENZYME CORPORATION | 11 | $313 |
| Mallinckrodt Hospital Products Inc. | 10 | $285 |
| Regeneron Healthcare Solutions, Inc. | 12 | $276 |
| Insmed, Inc. | 21 | $249 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $201 |
| Viatris Specialty LLC | 11 | $180 |
| Grifols USA, LLC | 6 | $165 |
Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, Ohtuvayre, ACTHAR, AIRSUPRA, Arikayce, FASENRA.
Industry payments across PA — which companies pay providers there.
